Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Lancet Psychiatry – May 17, 2016
Source: PubMed
Summary
A single dose of psilocybin, combined with therapeutic support, showed significant promise for individuals struggling with severe depression that hadn't responded to other treatments. This pioneering investigation explored whether this novel approach was practical and safe. Participants received psilocybin in a supportive setting. The findings indicated a substantial and rapid reduction in depressive symptoms for many, suggesting a new avenue for mental health care. This approach appears to be a viable and potentially transformative option.
Abstract
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.